GL1X · GenesisL1 explorer

MolNFT v1 · #110363 · protein

Crystal structure of the FLT3 kinase domain bound to the inhibitor quizartinib (AC220)

4XUF · Receptor-type tyrosine-protein kinase FLT3: “Crystal structure of the FLT3 kinase domain bound to the inhibitor quizartinib (AC220)”. X-ray diffraction, 1 ligand (P30), 4 pockets (best druggability 0.73). MolNFT v1 #110363 on…

PDB
4XUF
Type
protein
Length
544 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Receptor-type tyrosine-protein kinase FLT3
EC
2.7.10.1
UniProt
P36888
Ligands
P30
Pockets
4 · best druggability 0.73

Structure

x-ray diffraction · 2 distinct chains · 37% helix, 18% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AReceptor-type tyrosine-protein kinase FLT3 (EC 2.7.10.1)protein27037% helix, 19% strandP36888
BReceptor-type tyrosine-protein kinase FLT3 (EC 2.7.10.1)protein27436% helix, 18% strandP36888

Ligands and binding sites

  • P30 · 1-(5-tert-butyl-1,2-oxazol-3-yl)-3-(4-{7-[2-(morpholin-4-yl)ethoxy]imidazo[2,1-b][1,3]benzothiazol-2-yl}phenyl)urea · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
15320.730.8162P30
24820.710.8157P30
33020.570.7736empty
41070.390.7523empty

Interfaces

1 interface between chains.

  • A–B · 373 Ų buried · 1 hydrogen bond · protein-protein

Compared structures

  • 4XUF · Crystal structure of the FLT3 kinase domain bound to the inhibitor quizartinib (AC220) · the same entry in another collection · chain A against A, TM-score 1.00
  • P36888 · AlphaFold monomer V2.0 prediction for receptor-type tyrosine-protein kinase FLT3 (P36888) · a predicted model of the same protein · chain A against A, TM-score 0.98

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.